The first thing I have to figure out is which pathway is actually in play, because the three most common cancer claims in this field don't run on the same track. Cervical cancer cases usually turn on screening intervals, how an abnormal result was managed, colposcopy, whether pathology was communicated properly, or a patient lost to follow-up. Endometrial cancer claims tend to center on postmenopausal bleeding, or abnormal uterine bleeding that should have prompted evaluation. Ovarian cancer is different still — those cases usually come down to symptoms, imaging, how an adnexal mass was risk-assessed, referral, and follow-up, since there's no routine population screening the way there is for cervical cancer.
A reliable analysis requires the longitudinal record rather than only the visit closest to diagnosis, including outside pathology, every lab and imaging report, patient communications, referral orders, recall systems, any missed appointments, and the eventual oncologic staging. And whatever recommendations apply have to be matched precisely to that patient's age, risk profile, prior results, symptoms, and the actual date of care — not to a generic standard pulled from a different point in time.
From the plaintiff side, a case might turn on bleeding that wasn't acted on, an abnormal test that got no follow-up, a mass that persisted without further workup, escalating symptoms, results that were poorly communicated, or a tracking system that simply let the patient fall through. From the defense side, the record might show screening that was entirely appropriate, symptoms that were nonspecific or only just emerging, prior testing that was genuinely reassuring, follow-up that was reasonable, a patient who didn't show up despite real outreach efforts, or tumor biology aggressive enough that timing wouldn't have changed much anyway.
Causation in these cases has to be oncology-specific — there's no shortcut around that. An expert needs to address whether the cancer was probably present and detectable at the earlier date being alleged, what stage it likely would have been and how it would have been treated then, the tumor's biology, and whether the delay probably changed survival, the intensity of treatment needed, fertility, or whatever outcome is actually being claimed. I'll say this plainly: lost time alone is not a complete causation opinion. It has to connect to something measurable.
Questions for Counsel
- What was the presenting symptom that should have triggered a workup — postmenopausal bleeding, abnormal Pap smear, adnexal mass on imaging — and is there documentation of that symptom in the medical record?
- What workup was performed in response to the presenting symptom, and does that workup meet the ACOG standard — and if not, what workup was required and why was it not performed?
- What is the cancer stage at diagnosis, and what would the stage have been at the point of the alleged departure — and has an oncology expert addressed the difference in survival probability between those stages?
- Are there prior visits where the same symptom was documented but not appropriately evaluated — and how many visits and how much time elapsed between the first documented symptom and the eventual diagnosis?
- Did the patient's treatment change as a result of the delayed diagnosis — specifically, would earlier-stage disease have been treatable with less aggressive surgery, lower radiation dose, or without chemotherapy?
Disclaimer: This material is for general educational purposes and does not constitute legal advice, medical advice, or a case-specific standard-of-care or causation opinion. Clinical guidance changes over time. Every matter requires review of the complete record, applicable guidance in effect on the date of care, local resources, and jurisdiction-specific legal standards. For consultation on a specific case, contact OBGYN Peer.